Literature DB >> 8810648

T cells are the predominant source of interleukin-5 but not interleukin-4 mRNA expression in the lungs of antigen-challenged allergic mice.

C G Garlisi1, A Falcone, M M Billah, R W Egan, S P Umland.   

Abstract

Pulmonary inflammation is characterized by the accumulation of eosinophils and other leukocytes in the lungs of individuals challenged with antigen. Cytokines released by the Th2 lymphocyte subset, especially interleukin-4 (IL-4) and interleukin-5 (IL-5), are also present and thought to play an important role in this process. Previously, we used a model of aerosolized antigen challenge of sensitized mice to show that T cells were necessary for the accumulation of eosinophils and the production of cytokine steady-state messenger ribonucleic acid (mRNA). T cells were isolated from lung tissue at a time (4 h) when high levels of IL-4 and IL-5 mRNAs had accumulated, and from bronchoalveolar lavage fluid (BALF) and lung tissue at a later time (24 h), when inflammation could be detected by lavage. Lung-derived lymphocytes from sensitized challenged mice consisted of approximately 40% Thyl+ T cells (20% CD4+, 13% CD8+, and 6% CD4+/CD8+) and 30% B220+ B cells. Both BALF- and lung-derived T lymphocytes exhibited a similar activated/memory phenotype (CD44+ CD45RBlo), although lung tissue also contained less differentiated cells (CD44+ CD45RBhi). Thyl+ BALF cells isolated by magnetic bead-mediated separation accounted for approximately 88% of the IL-5 mRNA, 21% of the interferon-gamma (IFN-gamma) mRNA, and < 2% of the IL-4 mRNA detected in unseparated samples by reverse transcriptase-polymerase chain reaction (RT-PCR). Thyl+ T cells from lung tissue accounted for approximately 98% and 89% of IL-5 mRNA, 56% and 80% of IFN-gamma mRNA, and 23% and 40% of IL-4 mRNA at 4 h and 24 h after challenge, respectively. These experiments demonstrate that isolated T cells from BALF and lung are responsible for most of the IL-5 mRNA, but not all of the IFN-gamma or IL-4 mRNAs, detected in this model. These results are consistent with human studies indicating T cells as the major source of IL-5 mRNA in the lungs of asthmatic patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8810648     DOI: 10.1165/ajrcmb.15.3.8810648

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  6 in total

Review 1.  Effects of anti-IgE in asthmatic subjects.

Authors:  A J Frew
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

2.  Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice.

Authors:  X F Lei; Y Ohkawara; M R Stämpfli; C Mastruzzo; R A Marr; D Snider; Z Xing; M Jordana
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

3.  Hyposensitization to allergic reaction in rDer f 2-sensitized mice by the intranasal administration of a mutant of rDer f 2, C8/119S.

Authors:  M Yasue; T Yokota; M Fukada; T Takai; M Suko; H Okudaira; Y Okumura
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

4.  Histamine H4 receptor antagonism diminishes existing airway inflammation and dysfunction via modulation of Th2 cytokines.

Authors:  Jeffery M Cowden; Jason P Riley; Jing Ying Ma; Robin L Thurmond; Paul J Dunford
Journal:  Respir Res       Date:  2010-06-24

5.  The Role of Plasmacytoid and Myeloid Dendritic Cells in Induction of Asthma in a Mouse Model and the Effect of a TLR9 Agonist on Dendritic Cells.

Authors:  Ji-Hun Mo; Young-Jun Chung; Tomoko Hayashi; Jongdae Lee; Eyal Raz
Journal:  Allergy Asthma Immunol Res       Date:  2011-05-23       Impact factor: 5.764

Review 6.  Paget's disease of bone: an osteoimmunological disorder?

Authors:  Mohamed S Numan; Nathalie Amiable; Jacques P Brown; Laëtitia Michou
Journal:  Drug Des Devel Ther       Date:  2015-08-14       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.